You have 8 free searches left this month | for more free features.

Aluminum sulfate

Showing 1 - 25 of 967

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Aluminum Phosphide Poisoning Trial in Tanta (gastric lavage with paraffin oil and bicarbonate, gastric lavage with coconut oil

Completed
  • Aluminum Phosphide Poisoning
  • gastric lavage with paraffin oil and bicarbonate
  • +3 more
  • Tanta, Egypt
    Tantau
Jun 6, 2022

HIV Trial in Columbus, Pittsburgh (Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant, Placebo control for Trimer 4571 vaccine

Recruiting
  • HIV Infections
  • Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant
  • +3 more
  • Columbus, Ohio
  • +1 more
Apr 10, 2022

Aluminium Phosphide Poisoning Trial (Routine management, CRRT, PPH)

Not yet recruiting
  • Aluminium Phosphide Poisoning
  • Routine management
  • +2 more
  • (no location specified)
Apr 12, 2022

COVID-19 (Healthy Volunteers) Trial in Korea, Republic of (GBP510 adjuvanted with Alum (RBD 10µg/dose) - Stage 1, Normal saline

Active, not recruiting
  • COVID-19 (Healthy Volunteers)
  • GBP510 adjuvanted with Alum (RBD 10μg/dose) - Stage 1
  • +5 more
  • Ansan, Korea, Republic of
  • +11 more
May 9, 2022

Lyme Borreliosis, Nervous System Trial in La Mesa, Lincoln, Ghent (VLA15 with Alum, VLA15 without Alum)

Completed
  • Lyme Borreliosis, Nervous System
  • VLA15 with Alum
  • VLA15 without Alum
  • La Mesa, California
  • +2 more
Dec 16, 2022

COVID-19 Trial in Bloemfontein, Pretoria, Soweto (Candidate vaccine, SCB-2020S, Candidate vaccine, SCB-2019, Squalene based

Active, not recruiting
  • COVID-19
  • Candidate vaccine, SCB-2020S
  • +3 more
  • Bloemfontein, South Africa
  • +2 more
Oct 18, 2022

Selected Macroelements in Premature Ovarian Insufficiency

Recruiting
  • Premature Ovarian Failure
  • ultrasound assessment
  • Gaziantep, Turkey
    Cengiz Gokcek Women's and Children's Hospital.
Aug 30, 2021

COVID-19 (Healthy Volunteers) Trial in Seongnam-si, Seoul (NBP2001 adjuvanted with alum (RBD 30µg/dose), NBP2001 adjuvanted with

Active, not recruiting
  • COVID-19 (Healthy Volunteers)
  • NBP2001 adjuvanted with alum (RBD 30μg/dose)
  • +2 more
  • Seongnam-si, Bundang, Korea, Republic of
  • +1 more
May 9, 2022

COVID-19 Trial in Nedlands (SCB-2019, SCB-2019 with AS03 adjuvant, SCB-2019 with CpG 1018 adjuvant plus Alum adjuvant)

Completed
  • COVID-19
  • SCB-2019
  • +3 more
  • Nedlands, Western Australia, Australia
    Linear Clinical Research Ltd
Feb 17, 2022

COVID-19, SARS-CoV2 Infection Trial in New Haven (Neosporin, Vaseline)

Recruiting
  • COVID-19
  • SARS-CoV2 Infection
  • New Haven, Connecticut
    Yale University
Sep 12, 2022

Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)

Recruiting
  • Advanced Solid Tumor
  • +8 more
  • CNSI-Fe(II) 30 mg
  • +2 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Sep 15, 2023

Type I Diabetes Trial in Birmingham (Placebo GABA and Placebo GAD-alum, GABA and Placebo GAD-alum, Active Oral GABA and Active

Completed
  • Type I Diabetes
  • Placebo GABA and Placebo GAD-alum
  • +2 more
  • Birmingham, Alabama
    Children's of Alabama
May 2, 2022

Colonoscopy Trial (DWJ1609, DWC202304)

Not yet recruiting
  • Colonoscopy
  • (no location specified)
Sep 24, 2023

HPV Infection Trial in H?i Phòng (Gardasil®, Merck)

Active, not recruiting
  • HPV Infection
  • Gardasil®, Merck
  • Hải Phòng, Vietnam
    Hai Phong District Health Centre
Sep 20, 2022

Cholera Vaccination Reaction Trial in Seoul (OSP:rTTHc Cholera Conjugate Vaccine Cohort A, OSP:rTTHc Cholera Conjugate Vaccine

Recruiting
  • Cholera Vaccination Reaction
  • OSP:rTTHc Cholera Conjugate Vaccine Cohort A
  • +8 more
  • Seoul, Korea, Republic of
  • +2 more
Nov 30, 2022

Chronic HIV Infection Trial in United States (426c.Mod.Core-C4b, Adjuvant 3M-052-AF+Alum)

Not yet recruiting
  • Chronic HIV Infection
  • 426c.Mod.Core-C4b
  • Adjuvant 3M-052-AF+Alum
  • Birmingham, Alabama
  • +6 more
Aug 17, 2023

Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)

Recruiting
  • Bowel Preparation
  • Nanjing, Jiangsu, China
    A single-center, single-blind, randomized controlled clinical st
Oct 20, 2023

Insemination, Artificial Trial in Saint-Étienne (samples of sperm)

Completed
  • Insemination, Artificial
  • samples of sperm
  • Saint-Étienne, France
    CHU de Saint Etienne
Mar 10, 2022

Post-ERCP Bleeding Trial (Sucralfate)

Not yet recruiting
  • Post-ERCP Bleeding
  • (no location specified)
Oct 27, 2023

Aluminium Overload, Biological Availability Trial in Guadalupe, Reus (ORGONO Living Silica Acacia Gum-MMST Powder, ORGONO Living

Completed
  • Aluminium Overload
  • Biological Availability
  • ORGONO Living Silica Acacia Gum-MMST Powder
  • +3 more
  • Guadalupe, Murcia, Spain
  • +1 more
Sep 15, 2022

Healthy, Irritation/Irritant, Reactions Adverse Trial (NS Solution, Normal Saline, SLS)

Completed
  • Healthy
  • +2 more
  • NS Solution
  • +2 more
  • (no location specified)
Nov 1, 2023

Neodymium-doped Yttrium Aluminum Garnet Laser Capsulotomy

Active, not recruiting
  • Posterior Capsule Opacification Obscuring Vision
  • Neodymium-doped Yttrium Aluminum Garnet (Nd: YAG) Laser Capsulotomy
  • Tahlequah, Oklahoma
    Northeastern State University
Aug 30, 2022

Potential Therapeutic Role Trial in Tanta (Hydroxyethyl Starch 130-0.4 60 MG/ML [Voluven], Hydrocortisone, Placebo)

Unknown status
  • Potential Therapeutic Role
  • Hydroxyethyl Starch 130-0.4 60 MG/ML [Voluven]
  • +2 more
  • Tanta, El Gharbyia, Egypt
    Tarek Abdel Hay
Jul 22, 2020

Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

Recruiting
  • Hepatitis B
  • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
  • +4 more
  • Cambridge, United Kingdom
    GSK Investigational Site
Jan 12, 2023

Pharmacokinetics Trial in Hong Kong (Atropine sulfate eye drops)

Recruiting
  • Pharmacokinetics
  • Atropine sulfate eye drops
  • Hong Kong, China
    HKU Eye Centre
May 2, 2023